or Try an Advanced Search...

    Technical Analysis for PHIO - Phio Pharmaceuticals Corp.

    Grade Last Price % Change Price Change
    F 0.67 -4.14% -0.03
    PHIO closed down 4.14 percent on Wednesday, April 24, 2024, on 19 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PHIO trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Calm After Storm Range Contraction 0.00%
    Fell Below 50 DMA Bearish -4.14%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.14%
    20 DMA Support Bullish -4.14%
    Bollinger Band Squeeze Range Contraction -4.14%
    Calm After Storm Range Contraction -4.14%
    BB Squeeze + Upper Band Touch Range Contraction -4.14%
    BB Squeeze Started Range Contraction -4.14%
    Older End-of-Day Signals for PHIO ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 19 hours ago
    Non-ADX 1,2,3,4 Bearish Retracement Entry about 19 hours ago
    Fell Below Previous Day's Low about 19 hours ago
    20 DMA Support about 22 hours ago
    10 DMA Support about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PHIO Chart by TradingView
    Basic chart:

    Profile

    RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology

    Is PHIO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 22 Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
    Apr 16 Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
    Apr 11 Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
    Apr 3 National Spotlight Features Phio’s Innovative RNAi Technology Platform
    Apr 2 Phio Pharmaceuticals GAAP EPS of -$5.20
    Apr 2 Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
    Mar 21 Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
    Mar 13 Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research
    Mar 6 Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
    Jan 31 Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
    See more PHIO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.85
    52 Week Low 0.5
    Average Volume 486,279
    200-Day Moving Average 1.31
    50-Day Moving Average 0.80
    20-Day Moving Average 0.68
    10-Day Moving Average 0.68
    Average True Range 0.09
    RSI (14) 45.05
    ADX 23.49
    +DI 34.77
    -DI 13.03
    Chandelier Exit (Long, 3 ATRs) 0.77
    Chandelier Exit (Short, 3 ATRs) 0.89
    Upper Bollinger Bands 0.76
    Lower Bollinger Band 0.61
    Percent B (%b) 0.41
    BandWidth 23.10
    MACD Line -0.03
    MACD Signal Line -0.04
    MACD Histogram 0.0084
    Fundamentals Value
    Market Cap 3.07 Million
    Num Shares 4.57 Million
    EPS -7.43
    Price-to-Earnings (P/E) Ratio -0.09
    Price-to-Sales 48.01
    Price-to-Book 0.37
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.77
    Resistance 3 (R3) 0.78 0.75 0.76
    Resistance 2 (R2) 0.75 0.72 0.75 0.75
    Resistance 1 (R1) 0.71 0.71 0.70 0.71 0.74
    Pivot Point 0.68 0.68 0.67 0.68 0.68
    Support 1 (S1) 0.64 0.65 0.63 0.64 0.60
    Support 2 (S2) 0.61 0.64 0.61 0.59
    Support 3 (S3) 0.57 0.61 0.59
    Support 4 (S4) 0.57